Celgene Corporation (NASDAQ:CELG) – Survey Reveals People With Early And Late-stage Pancreatic Cancer Do Not Discuss Clinical Trials With Their Doctors

[at noodls] – Pancreatic Cancer Action Network and Celgene Join Together to Raise Awareness about Pancreatic Cancer Through a First-of-its-kind Survey Offering a Rare Glimpse of those Living with and Caring for Pancreatic . . . → Read More: Celgene Corporation (NASDAQ:CELG) – Survey Reveals People With Early And Late-stage Pancreatic Cancer Do Not Discuss Clinical Trials With Their Doctors Similar Articles: Amgen Inc. (NASDAQ:AMGN) – Amgen cholesterol drug succeeds in late-stage trial Company Update: Johnson & Johnson (NYSE:JNJ) – AstraZeneca to co-promote J&J prostate cancer drug in Japan German ZEW survey on tap